http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE42748-E

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_058e0be30e00d53858c67167df60aed5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M36-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00
filingDate 2011-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e5f6792f7dba6e08c71a95bbf3c75b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e914957fe432932fb7413225752c4dcc
publicationDate 2011-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-RE42748-E
titleOfInvention Oral DTPA for radionuclide chelation
abstract A composition for oral radionuclide chelation therapy comprises a DTPA chelate selected from Zn-DTPA and Ca-DTPA and a permeation enhancer that preferentially increases jejunal uptake of the DTPA chelate. The composition has a DTPA chelate bioavailability of at least 10% of the chelate when orally administered to a mammal.
priorityDate 2006-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6017522-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5730968-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004191169-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008029625-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129233874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129204988
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135781492
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22770772
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2520
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10953859
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID117319
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441074
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129568334
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412164
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226920223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87133450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129054986
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407258
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID103023
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406192
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724385

Total number of triples: 55.